Dequalinium chloride inhibits the growth of human glioma cells in vitro and vivo: a study on molecular mechanism and potential targeted agents
- 14 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neurochirurgica
- Vol. 162 (7), 1683-1690
- https://doi.org/10.1007/s00701-020-04401-x
Abstract
Background Our current understanding of the role of dequalinium chloride (DECA) in the progression of glioma remains very limited. This study was aimed to investigate the effect of DECA on human glioma cell lines in vitro and vivo. Methods The underlying molecular mechanism was analyzed for developing potential targeted agents. MTT assay, genomic DNA electrophoresis, DAPI staining, TUNEL staining, and wound scratch assay were performed to evaluate the effect of DECA on human glioma cell lines. Bioinformatics methods were used to screen the possible signaling pathway proteins, and the expression of these proteins and the corresponding mRNA was measured. Results DECA significantly inhibited the growth and proliferation of human glioma cells. Screening of apoptosis-related proteins showed the mRNA expression level of 6 genes was significantly changed after DECA administration. Conclusion This study shows that DECA effectively inhibits the growth of glioma cells in vitro and vivo. DECA may promote glioma cell apoptosis by affecting the expression of NFKB2, HRAS, NF1, CBL, RAF1, and BCL-2 genes.Keywords
Funding Information
- Jilin Provincial Health and Family Planning Commission (NO.2017J045)
This publication has 20 references indexed in Scilit:
- The Role of Platelets in Cancer Pathophysiology: Focus on Malignant GliomaCancers, 2019
- Intracranial Nonskull-Based Chondrosarcoma Arising from the Sagittal Sinus: A Case Report and Review of the LiteratureWorld Neurosurgery, 2018
- XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cellsOncotarget, 2014
- Long-term treatment with temozolomide in malignant gliomaJournal of Clinical Neuroscience, 2014
- Central Diabetes Insipidus: A Previously Unreported Side Effect of TemozolomideJournal of Clinical Endocrinology & Metabolism, 2013
- Glioblastoma MultiformeHematology/Oncology Clinics of North America, 2012
- Dequalinium induces human leukemia cell death by affecting the redox balanceLeukemia Research, 2011
- Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology ConsortiumCancer, 2008
- Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines: Mitochondrial implication in cell deathLeukemia Research, 2005
- Telomerase and telomere stability: A new class of tumor suppressor?Molecular Carcinogenesis, 2000